The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA.
In the present study we try to define the optimal conditions for preparation of copper-oxidized low-density lipoprotein (oxLDL) to be used for the assay of oxLDL antibodies by enzyme immunoassay (EIA). Oxidation of LDL was monitored by measuring the formation of conjugated dienes at 234 nm and the generation of fluorescent products with emission at 430 nm when excitation is performed at 360 nm. The generation of immunogenic epitopes was evaluated by testing the reactivity of aliquots collected at different times during the oxidation process with human sera with high oxLDL antibody levels and with a purified human oxLDL antibody. The values of fluorescence emission at 430 nm correlated best with reactivity with oxLDL antibodies; strong reactivity was usually associated with values greater than 1.1 U. The time needed for fluorescence emission to reach maximum levels varied between 6 and 14 h for most LDL, but it was considerably longer in a few LDL preparations. The maximal reactivity of oxLDL with oxLDL antibodies was observed when the LDL oxidation reaction was stopped 4 or more hours after the fluorescence readings reached their peak. At this stage of the oxidation reaction, apolipoprotein B fragmentation and aggregation were observed as shown by Western blot analysis. The CV for 13 EIA runs of two reference oxLDL antibodies reacting with four different pools of standardized oxLDL prepared according to the stated guidelines was 14.5 and 3.9%, confirming the reproducibility of our oxidation conditions.
Lopes-Virella
M F
MF
Division of Endocrinology, Diabetes and Medical Genetics, Department of Medicine, Ralph H. Johnson VA Medical Center, Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA. virellam@musc.edu
Koskinen
S
S
Mironova
M
M
Horne
D
D
Klein
R
R
Chassereau
C
C
Enockson
C
C
Virella
G
G
D000936:Antigen-Antibody Complex / Q000032:analysis; D001161:Arteriosclerosis / Q000276:immunology*; D001323:Autoantibodies / Q000097:blood*; D003300:Copper / Q000378:metabolism; D006801:Humans; D007124:Immunoenzyme Techniques; D008077:Lipoproteins, LDL / Q000276:immunology* / Q000378:metabolism*; D010084:Oxidation-Reduction; D012680:Sensitivity and Specificity
D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D008077:Lipoproteins, LDL; D003300:Copper